[Form 4] HELIOS TECHNOLOGIES, INC. Insider Trading Activity

Rhea-AI Filing Summary

Diana Sacchi, a director of Helios Technologies, Inc. (HLIO), filed a Form 4 reporting transactions dated 10/04/2025. The filing shows a non-derivative transaction involving 914 shares of common stock at a price of $52.77, and reports 7,543 shares beneficially owned by the reporting person following the reported transaction. The filing also lists 914 restricted stock units (RSUs) mapped to 914 underlying common shares with an indicated price of $0 and 0 RSUs remaining beneficially owned after the transaction. The form is signed by an attorney-in-fact on behalf of the reporting person.

Positive

• Director retains 7,543 shares after the reported transaction
• Transaction details fully disclosed with share count and price ($52.77)

Negative

• Reported RSUs map to 914 underlying shares with 0 RSUs remaining

Insights

Corporate Governance Analyst

Director reported a 914-share equity transaction, leaving 7,543 shares beneficially owned.

The filing records a non-derivative entry for 914 common shares at $52.77 on 10/04/2025

Key dependencies include the director's remaining holdings of 7,543 shares and the listed 914 RSUs tied to 914 common shares with an indicated $0 price and 0 RSUs reported as remaining. Watch for any future Form 4s indicating additional sales or acquisitions that would change the director's ownership over the next several reporting periods.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Sacchi Diana

(Last) (First) (Middle)

C/O HELIOS TECHNOLOGIES, INC.

7456 16TH ST E

(Street)

SARASOTA FL 34243

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
HELIOS TECHNOLOGIES, INC. [ HLIO ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
10/04/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	10/04/2025		M		914	A	$52.77	7,543	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Units	(1)	10/04/2025		M			914	(1)	(1)	Common Stock	914	$0	0	D

Explanation of Responses:

1. Each RSU represents the right to receive, following vesting, one share of Common Stock. Upon vesting, there is no expiration.

	/s/ Marc Greenberg, Attorney-in-Fact for Diana Sacchi	10/07/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did HLIO director Diana Sacchi report on Form 4?

The Form 4 reports a non-derivative transaction of 914 common shares at $52.77 on 10/04/2025, and shows 7,543 shares beneficially owned after the transaction.

How many restricted stock units were disclosed in the HLIO filing?

The filing lists 914 restricted stock units representing 914 underlying common shares with an indicated price of $0 and reports 0 RSUs remaining beneficially owned.

Who signed the Form 4 for Diana Sacchi (HLIO)?

The Form 4 is signed /s/ Marc Greenberg, Attorney-in-Fact with a signature date of 10/07/2025.

What is the reporting date on the HLIO Form 4?

The earliest transaction date reported is 10/04/2025.